Advertisement
    In the last 4 hours
    In the last 7 days
    Does Moderna Need to Start Making Money? The Motley Fool12:45 9-Jun-26
    Moderna MRNA Stock 2026 Outlook: Buy or Sell the mRNA Pioneer? International Business Times - AU Edition13:17 7-Jun-26
    In the last month
    Three Ebola vaccine candidates fast-tracked as African outbreak continues Center for Infectious Disease Research and Policy21:22 1-Jun-26
    CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates Coalition for Epidemic Preparedness Innovations (Press Release)09:51 1-Jun-26
    The next era of healthcare is personal The McKinsey Quarterly20:30 21-May-26
    Hantavirus Has Low Pandemic Risk But Moderna Stays Vigilant Scrip Pharma Intelligence16:30 20-May-26
    Much Ado About “About” JD Supra15:28 15-May-26
    view more headlines
    10 Jun 23:11

    About our Moderna news

    Latest news on Moderna, a pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.